Cargando…
Progress of (18)F-flurpiridaz in Clinical Trials
(18)F-flurpiridaz is a novel positron emission computed tomography (PET) tracer in ongoing clinical trials in United States and Japan. A phase III prospective, open-label, multi-center study to assess the feasibility of (18)F-flurpiridaz was reported by Maddahi et al. in patients with known or suspe...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The Japanese Society of Nuclear Cardiology
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10696143/ http://dx.doi.org/10.17996/anc.23-00011 |